Centrexion Therapeutics has filed a notice of an exempt offering of securities to raise $12,859,762.00 in New Debt Financing.
According to filings with the U.S. Securities and Exchange Commission, Centrexion Therapeutics is raising $12,859,762.00 in new funding. Sources indicate that as part of senior management Chief Financial Officer, Michael Ward played a key role…
